Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.32908325
Author: Trendlyne DVM scores

about

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

8.24 -0.32 (-3.74%)

63.91% Fall from 52W High

1.7M

XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.8 / 100

Technically Neutral

37.3 / 100

1Yr Price target upside is 216%

6 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

63.91% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart